Acquisition by Caldini Filippo of 17910 shares of Establishment Labs at 44.06 subject to Rule 16b-3
ESTA Stock | USD 33.76 0.07 0.21% |
About 62% of Establishment Labs' investor base is looking to short. The analysis of overall sentiment of trading Establishment Labs Holdings stock suggests that many investors are alarmed at this time. The current market sentiment, together with Establishment Labs' historical and current headlines, can help investors time the market. In addition, many technical investors use Establishment Labs stock news signals to limit their universe of possible portfolio assets.
Establishment |
Filed transaction by Establishment Labs Holdings Officer President. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Establishment Labs Fundamental Analysis
We analyze Establishment Labs' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Establishment Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Establishment Labs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Establishment Labs is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Establishment Labs Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Establishment Labs stock to make a market-neutral strategy. Peer analysis of Establishment Labs could also be used in its relative valuation, which is a method of valuing Establishment Labs by comparing valuation metrics with similar companies.
Peers
Establishment Labs Related Equities
APYX | Apyx Medical | 4.11 | ||||
CNMD | CONMED | 0.67 | ||||
FNA | Paragon 28 | 0.31 | ||||
ITGR | Integer Holdings | 0.20 | ||||
LIVN | LivaNova PLC | 0.18 | ||||
GKOS | Glaukos Corp | 0.79 | ||||
ELMD | Electromed | 0.82 | ||||
SRDX | SurModics | 0.84 | ||||
LUNG | Pulmonx Corp | 2.40 | ||||
SGHT | Sight Sciences | 2.62 | ||||
KIDS | Orthopediatrics Corp | 2.82 | ||||
NPCE | Neuropace | 3.40 | ||||
TMCI | Treace Medical | 3.74 | ||||
INGN | Inogen | 4.63 |
Complementary Tools for Establishment Stock analysis
When running Establishment Labs' price analysis, check to measure Establishment Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Establishment Labs is operating at the current time. Most of Establishment Labs' value examination focuses on studying past and present price action to predict the probability of Establishment Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Establishment Labs' price. Additionally, you may evaluate how the addition of Establishment Labs to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |